BHC Earnings

BHC reported its earnings on 2026-04-29, showcasing a revenue of 2.52B against an estimate of 2.41B, resulting in a 4.73% surprise. The EPS was 0.78, surpassing the expected 0.81 by -3.7%. The stock experienced a 2.33% price change on the earnings day and a 0.89% change over the next five days, reflecting market reactions to the results.

Following BHC's earnings announcement on 2026-04-29, the stock price moved by 2.33% on the day of the release. Over the subsequent five days, it saw a 0.89% change. Historically, BHC's stock price tends to shift by an average of 1.25% in the 10 days leading up to earnings and 0.83% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate BHC's annual revenue to reach 2.61B, while the EPS is projected at 0.96. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BHC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BHC's stock price typically moves by 1.25% in the 10 days before its earnings and 0.83% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.96 and revenue of 2.61B.

The earnings call showed strong financial performance with significant revenue growth in key segments like Salix and Solta, a net debt reduction, and a positive outlook for future growth. Despite some uncertainties, such as potential destocking and tariff impacts, management provided reassuring responses. The acquisition of Shibo and the strategic focus on high-growth areas like China and GI franchise investments are positive indicators. Given the market cap, the stock is likely to react positively, albeit moderately, to these developments.